Women's Health
Emsella vs. Surgery for Stress Incontinence: How the Evidence Compares
Surgery corrects anatomy better on paper, but Emsella offers faster recovery with no incisions and no infection risk. Here's what a head-to-head study actually found, and how to think about which option fits your situation.
TL;DR: In a 2025 comparative study of 133 women, surgery (anterior colporrhaphy) achieved better anatomical correction than Emsella (88% vs 64%), but Emsella had faster recovery, with 91% of patients resuming daily activities within a week, no infections, and no post-treatment pain during intimacy. Emsella is best positioned as the non-surgical first option for mild-to-moderate stress urinary incontinence, not a universal replacement for surgery in every case.
What Does the Head-to-Head Evidence Actually Show?
A 2025 prospective comparative study published in Healthcare (Sacarin et al.) followed 133 women with stress urinary incontinence, comparing outcomes between Emsella (HIFEM chair-based therapy) and surgical anterior colporrhaphy. The results are genuinely useful because they don't paint either option as universally superior, they show two different tradeoffs.
Surgery achieved anatomical correction in 88% of patients, compared to 64% for Emsella. On a pure structural-repair basis, surgery outperformed. But Emsella patients had a meaningfully easier recovery: 91% resumed daily activities within a week, versus a longer recovery window typical of surgical repair. Emsella also showed no infections and no dyspareunia (pain during intercourse) in the study, both real considerations after any pelvic surgical procedure.
Emsella vs. Surgical Anterior Colporrhaphy: Study Comparison
| Outcome | Emsella (HIFEM) | Surgery (Anterior Colporrhaphy) |
|---|---|---|
| Anatomical correction | 64% | 88% |
| Resumed daily activities within 1 week | 91% | Longer typical recovery |
| Infections reported | None | Surgical infection risk applies |
| Dyspareunia (pain with intercourse) | None reported | A recognized surgical risk |
| Invasiveness | Non-invasive, no incisions | Surgical incisions required |
Source: Sacarin G et al., "Prospective Comparative Study of EMSella Therapy and Surgical Anterior Colporrhaphy," Healthcare 2025;13(8):864.
What Does This Actually Mean for Choosing Between Them?
The honest reading of this data: surgery remains the stronger option when the anatomical correction itself is the priority, typically in more severe prolapse-related cases where structural repair is the main goal. Emsella is the stronger option when someone wants meaningful symptom improvement without incisions, without surgical recovery time, and without the infection and dyspareunia risks that come with any surgical procedure, particularly for mild-to-moderate stress urinary incontinence.
This is exactly why Emsella is positioned as the "no-surgery-first" option, not a guaranteed surgery replacement. For some women, Emsella's results are enough. For others with more significant anatomical issues, surgery may still be the more appropriate path, and that's a conversation for a real assessment, not a marketing claim either way.
What Does the Broader Emsella Evidence Base Show, Beyond This One Study?
Beyond the surgical comparison, several other studies support Emsella's use for stress urinary incontinence specifically:
- A foundational trial (Samuels et al. 2019) of 75 women found 81.3% reported significant symptom reduction after six HIFEM sessions, with ICIQ-SF score improving 49.9% post-treatment and 64.4% at three-month follow-up
- A 2025 systematic review and meta-analysis (Leonardo et al.) pooling seven studies found significantly greater reduction in incontinence episodes compared to control groups, with no safety issues identified across studies
- A comparative study against electrostimulation (Silantyeva et al. 2021) found HIFEM produced significantly greater improvement in pelvic floor disability scores than electrostimulation in 95 parous women
What Emsella Cannot Do, Honestly
Emsella is not proven to replace surgery for all cases, the evidence directly shows surgery achieves better anatomical correction. It should not be presented as a guarantee of specific personal results, the honest framing is "clinically studied to significantly reduce symptoms in the majority of patients," not "you will stop leaking." And like any pelvic health treatment, it works best after a real assessment confirms it's appropriate for your specific symptom pattern and severity, not as a generic add-on offered to everyone regardless of fit.
How Do I Know Which Option Is Right for Me?
A proper evaluation looks at your specific symptom severity, whether structural prolapse is a significant factor, your recovery time preferences, and your comfort with a surgical versus non-surgical approach. This isn't a decision to make from a comparison chart alone, it's one to make with a physician who has actually assessed your situation and can speak honestly about which option, or which sequence of options, fits your case.
How AION Approaches This Comparison
AION's Emsella program is positioned honestly within this evidence picture: a non-surgical first option with strong symptom-improvement data, not a universal surgery replacement. The assessment-first consultation exists specifically to have this conversation directly, matching the right option to your actual situation rather than defaulting to either path.
Related AION Resources
For a closer look at the intimacy-related benefits some women report, see our upcoming guide on Emsella and sexual function. For the male counterpart of this therapy, see our guide on post-prostatectomy incontinence and plasma exchange treatment options.
FAQ
Is Emsella as effective as surgery for stress incontinence? Not for anatomical correction specifically, surgery achieved 88% correction versus 64% for Emsella in a 2025 comparative study. But Emsella offered faster recovery and no infections or dyspareunia.
Who is a better candidate for surgery than Emsella? Women with more significant structural prolapse where anatomical correction is the primary goal may be better served by surgery, decided through a proper assessment.
Does Emsella have any surgical risks? No. It's non-invasive with no incisions, and the comparative study reported no infections or dyspareunia, unlike the surgical comparison group.
How much symptom improvement does Emsella actually provide? A foundational study found 81.3% of women reported significant symptom reduction after six sessions, with meaningful ICIQ-SF score improvement sustained at three-month follow-up.
Can I try Emsella before considering surgery? This is a reasonable approach for many women with mild-to-moderate symptoms, which is why Emsella is often positioned as the non-surgical first option, though the right sequence depends on your specific evaluation.
Does Emsella guarantee I'll stop leaking completely? No. The honest, evidence-based claim is significant symptom reduction in the majority of patients, not a guaranteed personal outcome.
This article is for educational purposes and does not replace individualized medical advice. Always discuss which treatment option fits your specific situation with a physician.
Relevant at AION
This article is educational and is not medical advice. Whether any therapy is appropriate for you is a clinical decision made by a physician after an individual assessment.
